(Q34099972)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108788%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

review article

1 reference

title

The physiopathological significance of ceruloplasmin. A possible therapeutic approach (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108788%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108788%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

G Floris

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108788%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A Padiglia

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108788%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

G Musci

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108788%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

1 December 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108788%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

published in

Biochemical Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108788%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108788%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108788%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

1735-1741

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108788%20AND%20SRC:MED&resulttype=core&format=json

Investigations in Serum Copper. II. Isolation of the Copper Containing Protein, and a Description of some of its Properties

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Purification and characterization of Fet3 protein, a yeast homologue of ceruloplasmin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

High-potential states of blue and purple copper proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

The influence of axial ligands on the reduction potential of blue copper proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

X-ray crystal structure of the blue oxidase ascorbate oxidase from zucchini. Analysis of the polypeptide fold and a model of the copper sites and ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Structural and Functional Aspects of Metal Sites in Biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Effect of pH on electron-paramagnetic-resonance spectra of ceruloplasmin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

The stoichiometry of the paramagnetic copper and the oxidation-reduction potentials of type I copper in human ceruloplasmin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

The state of the copper sites in human ceruloplasmin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Spectroscopic and magnetic studies of human ceruloplasmin: identification of a redox-inactive reduced Type 1 copper site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

On the lability and functional significance of the type 1 copper pool in ceruloplasmin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Evidence for ceruloplasmin as a copper transport protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Regulation of aortic CuZn-superoxide dismutase with copper. Caeruloplasmin and albumin re-activate and transfer copper to the enzyme in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Regulation of Cu,Zn superoxide dismutase with copper. Caeruloplasmin maintains levels of functional enzyme activity during differentiation of K562 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Copper as a cofactor and regulator of copper,zinc superoxide dismutase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Copper transport from ceruloplasmin: characterization of the cellular uptake mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Ascorbate enhances copper transport from ceruloplasmin into human K562 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Specific receptor for ceruloplasmin in membrane fragments from aortic and heart tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Ceruloplasmin receptors in liver cell suspensions are limited to the endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Purification and partial characterization of ceruloplasmin receptors from rat liver endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Ceruloplasmin receptors of erythrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Characterisation of the copper uptake mechanism and isolation of the ceruloplasmin receptor/copper transporter in human placental vesicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Cytochrome oxidase deficiency in Wilson's disease: a suggested ceruloplasmin function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Practical recommendations and new therapies for Wilson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Treatment and management of Wilson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Inhibition of endothelial nitric-oxide synthase by ceruloplasmin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Ceruloplasmin stimulates thymidine incorporation by CCL-39 cells in the absence of serum or growth factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Ceruloplasmin stimulates NADH oxidation of pig liver plasma membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Iron reverses impermeable chelator inhibition of DNA synthesis in CCl 39 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

The antioxidants of human extracellular fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Intact human ceruloplasmin oxidatively modifies low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Identification of the prooxidant site of human ceruloplasmin: a model for oxidative damage by copper bound to protein surfaces

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Ceruloplasmin copper induces oxidant damage by a redox process utilizing cell-derived superoxide as reductant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

The role of ceruloplasmin in iron metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Ceruloplasmin and Maternal Iron Mobilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Aceruloplasminemia: molecular characterization of this disorder of iron metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Role of ceruloplasmin in cellular iron uptake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

The FET3 gene of S. cerevisiae encodes a multicopper oxidase required for ferrous iron uptake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

The FET3 gene product required for high affinity iron transport in yeast is a cell surface ferroxidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

An oxidase-permease-based iron transport system in Schizosaccharomyces pombe and its expression in Saccharomyces cerevisiae.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Ceruloplasmin ferroxidase activity stimulates cellular iron uptake by a trivalent cation-specific transport mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Role of ceruloplasmin and ascorbate in cellular iron release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Glycosyl Phosphatidylinositol-Anchored Ceruloplasmin Is Expressed by Rat Sertoli Cells and Is Concentrated in Detergent-Insoluble Membrane Fractions1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Mitochondrial function is differentially affected upon oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Oxidative damage to sarcoplasmic reticulum Ca2+-ATPase AT submicromolar iron concentrations: evidence for metal-catalyzed oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Cellular iron metabolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Nitrosothiol formation catalyzed by ceruloplasmin. Implication for cytoprotective mechanism in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Copper supplementation of adult men: effects on blood copper enzyme activities and indicators of cardiovascular disease risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

The pH optimum for ceruloplasmin oxidase activity in the plasma of several species of animal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Modulation of the redox state of the copper sites of human ceruloplasmin by chloride.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

The multifunctional oxidase activity of ceruloplasmin as revealed by anion binding studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Inhibition of Biogenic Amine Uptake by Hydrogen Peroxide: A Mechanism for Toxic Effects of 6-Hydroxydopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Free radical-generated neurotoxicity of 6-hydroxydopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Some aspects of tyrosine secondary metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Dopamine receptors--physiological understanding to therapeutic intervention potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

"Rational hope" in the early treatment of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Levodopa in Parkinson's disease: neurotoxicity issue laid to rest?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Gene therapy for Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Astrocyte-specific expression of tyrosine hydroxylase after intracerebral gene transfer induces behavioral recovery in experimental parkinsonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Dopamine turnover and metabolism in the striatum of parkinsonian rats grafted with genetically-modified human astrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Astrocytes Promote or Impair the Survival and Function of Embryonic Ventral Mesencephalon Co-grafts: Effects of Astrocyte Age and Expression of Recombinant Brain-Derived Neurotrophic Factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

Generation of DOPA-producing astrocytes by retroviral transduction of the human tyrosine hydroxylase gene: in vitro characterization and in vivo effects in the rat Parkinson model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

The Biological Role of Ceruloplasmin and Its Oxidase Activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900399-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-2952(00)00399-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108788%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference